Researchers model familial amyloidosis in vitro using iPSC technology
Friday, November 1, 2013 - 12:00
in Health & Medicine
Researchers have generated the first known disease-specific induced pluripotent stem cell lines from a patient with familial transthyretin amyloidosis. The findings may lead to new treatments for genetic diseases, such as familial amyloidosis.